<DOC>
	<DOC>NCT00594334</DOC>
	<brief_summary>Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.</brief_summary>
	<brief_title>Effect of Actonel on Periodontal Health of Postmenopausal Women</brief_title>
	<detailed_description>Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.</detailed_description>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Osteopenia Postmenopausal Male Diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>osteopenia</keyword>
	<keyword>periodontitis</keyword>
</DOC>